Published in Stat Med on July 11, 2012
Trial to Compare Two Strains of BCG (STRAIN III) | NCT04383925
Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol (2014) 1.00
The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials. BMC Med Res Methodol (2014) 0.96
Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open (2016) 0.92
No solution yet for combining two independent studies in the presence of heterogeneity. Stat Med (2015) 0.81
Contour plot assessment of existing meta-analyses confirms robust association of statin use and acute kidney injury risk. J Clin Epidemiol (2015) 0.78
Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program. Stat Med (2013) 0.78
Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Med Res Methodol (2017) 0.76
Endoscopic and Open Release Similarly Safe for the Treatment of Carpal Tunnel Syndrome. A Systematic Review and Meta-Analysis. PLoS One (2015) 0.75
Sequential biases in accumulating evidence. Res Synth Methods (2015) 0.75
Power analysis for random-effects meta-analysis. Res Synth Methods (2017) 0.75
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med (1998) 19.07
Putting clinical trials into context. Lancet (2005) 7.29
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol (2007) 4.06
Sample sizes for clinical trials with normal data. Stat Med (2004) 3.47
A rational framework for decision making by the National Institute For Clinical Excellence (NICE). Lancet (2002) 3.26
Evaluation of experiments with adaptive interim analyses. Biometrics (1994) 3.02
Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol (2009) 2.39
Sequential methods for random-effects meta-analysis. Stat Med (2010) 2.33
The power of statistical tests in meta-analysis. Psychol Methods (2001) 2.21
Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report. J R Soc Med (2007) 1.95
Designed extension of studies based on conditional power. Biometrics (1995) 1.94
Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials (1997) 1.88
A general statistical principle for changing a design any time during the course of a trial. Stat Med (2004) 1.46
A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. Health Technol Assess (2004) 1.36
Evidence-based sample size calculations based upon updated meta-analysis. Stat Med (2007) 1.35
How useful are Cochrane reviews in identifying research needs? J Health Serv Res Policy (2007) 1.33
Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev (2003) 1.23
Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev (2006) 1.04
An encouraging assessment of methods to inform priorities for updating systematic reviews. J Clin Epidemiol (2008) 1.02
Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes. Clin Trials (2007) 0.94
Sample size recalculation using conditional power. Stat Med (2001) 0.90
Antibiotic prophylaxis in clean and clean-contaminated ear surgery. Cochrane Database Syst Rev (2004) 0.86
Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med (2006) 12.44
How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96
Comparison of two methods to detect publication bias in meta-analysis. JAMA (2006) 7.34
Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol (2007) 7.00
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Med Res Methodol (2006) 5.13
Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96
Evaluation of networks of randomized trials. Stat Methods Med Res (2007) 4.70
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med (2008) 4.34
Interpretation of random effects meta-analyses. BMJ (2011) 4.32
Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol (2002) 4.30
Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data. Ann Intern Med (2013) 4.02
Meta-analysis: The value of clinical assessment in the diagnosis of deep venous thrombosis. Ann Intern Med (2005) 3.73
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ (2006) 3.47
Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making (2012) 3.36
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials (2005) 3.19
Recent developments in meta-analysis. Stat Med (2008) 2.97
How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med (2005) 2.95
Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol (2008) 2.93
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet (2006) 2.72
Graphical tools for network meta-analysis in STATA. PLoS One (2013) 2.66
Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ (2008) 2.63
Synthesizing evidence on complex interventions: how meta-analytical, qualitative, and mixed-method approaches can contribute. J Clin Epidemiol (2013) 2.59
Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol (2002) 2.49
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol (2009) 2.45
Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making (2013) 2.43
Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med (2009) 2.43
Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making (2013) 2.39
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol (2009) 2.26
A systematic review of systematic reviews and meta-analyses of animal experiments with guidelines for reporting. J Environ Sci Health B (2006) 2.23
Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer (2005) 2.16
Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol (2009) 2.15
Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? Lancet (2005) 2.09
Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med (2009) 2.09
Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care. Value Health (2011) 2.05
Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study. BMC Med Res Methodol (2009) 2.01
Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol (2011) 1.97
Conceptual and technical challenges in network meta-analysis. Ann Intern Med (2013) 1.92
Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat Med (2009) 1.90
Finding qualitative research: an evaluation of search strategies. BMC Med Res Methodol (2004) 1.89
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ (2011) 1.86
Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med (2007) 1.83
STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest (2009) 1.82
Evaluation of inconsistency in networks of interventions. Int J Epidemiol (2013) 1.72
Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med (2005) 1.71
Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol (2008) 1.71
The effectiveness of anti-TNF-alpha therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis. Rheumatology (Oxford) (2010) 1.69
Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression. Trop Med Int Health (2014) 1.64
Hygiene and health: systematic review of handwashing practices worldwide and update of health effects. Trop Med Int Health (2014) 1.63
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med (2009) 1.60
Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies. BMC Med Res Methodol (2009) 1.51
The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol (2010) 1.49
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet (2009) 1.47
A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res (2004) 1.47
A network of investigator networks in human genome epidemiology. Am J Epidemiol (2005) 1.43
A multicomponent decision tool for prioritising the updating of systematic reviews. BMJ (2013) 1.42
Lack of evidence for the efficacy of memantine in mild Alzheimer disease. Arch Neurol (2011) 1.42
Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach. Health Econ (2011) 1.41
The use of systematic reviews when designing studies. Clin Trials (2005) 1.39
Are we sure about the evidence for zinc in prophylaxis of the common cold? Expert Rev Respir Med (2012) 1.38
Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists. Epidemiology (2017) 1.38
Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco. Cochrane Database Syst Rev (2015) 1.37
Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Syst Rev (2014) 1.36
Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med (2006) 1.35
The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS One (2013) 1.32
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol (2009) 1.25
Evidence synthesis for decision making 5: the baseline natural history model. Med Decis Making (2013) 1.25
Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach. Health Econ (2004) 1.24
Estimating within-study covariances in multivariate meta-analysis with multiple outcomes. Stat Med (2012) 1.23
A design-by-treatment interaction model for network meta-analysis with random inconsistency effects. Stat Med (2014) 1.21
Benefits and harms associated with hormone replacement therapy: clinical decision analysis. BMJ (2004) 1.18
Home safety education and provision of safety equipment for injury prevention. Cochrane Database Syst Rev (2012) 1.17
Evidence synthesis for decision making 7: a reviewer's checklist. Med Decis Making (2013) 1.16
A generalized weighting regression-derived meta-analysis estimator robust to small-study effects and heterogeneity. Stat Med (2012) 1.14
STrengthening the REporting of Genetic Association Studies (STREGA)--an extension of the STROBE statement. Genet Epidemiol (2009) 1.13
STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. Ann Intern Med (2009) 1.11
Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods. Stat Med (2008) 1.10
Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol (2010) 1.10
Bayesian meta-analysis and meta-regression for gene-disease associations and deviations from Hardy-Weinberg equilibrium. Stat Med (2007) 1.09
Evidence synthesis for decision making 1: introduction. Med Decis Making (2013) 1.09
Mixed treatment comparisons using aggregate and individual participant level data. Stat Med (2012) 1.08
Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. PLoS One (2012) 1.08
Bayesian multivariate meta-analysis with multiple outcomes. Stat Med (2013) 1.08
Comments on 'trying to be precise about vagueness' by Stephen Senn, Statistics in Medicine 2007; 26:1417-1430. Stat Med (2008) 1.07
Multivariate meta-analysis of mixed outcomes: a Bayesian approach. Stat Med (2013) 1.05
When is a further clinical trial justified? BMJ (2012) 1.03
Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event. BMC Med Res Methodol (2012) 1.01
Sensitivity analyses allowed more appropriate and reliable meta-analysis conclusions for multiple outcomes when missing data was present. J Clin Epidemiol (2004) 1.01
Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. Am J Epidemiol (2007) 1.01
Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis. J Clin Epidemiol (2012) 1.01
Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis. Stat Med (2014) 0.98